Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.850
-0.100 (-5.13%)
At close: Apr 28, 2026, 4:00 PM EDT
1.870
+0.020 (1.08%)
Pre-market: Apr 29, 2026, 7:59 AM EDT
Gain Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -20.16 | -20.41 | -22.27 | -17.59 | -13.89 | |
| Depreciation & Amortization | 0.05 | 0.04 | 0.04 | 0.03 | 0.02 | |
| Other Amortization | 0.05 | 0.05 | 0.05 | 0.04 | - | |
| Stock-Based Compensation | 1.8 | 2.39 | 3.26 | 1.53 | 0.84 | |
| Other Operating Activities | 0.8 | 0.14 | -0.38 | -0.21 | 1 | |
| Change in Accounts Receivable | - | - | - | - | 0.01 | |
| Change in Accounts Payable | -0.47 | 0.27 | -0.69 | 1.07 | -0.52 | |
| Change in Unearned Revenue | -0.33 | -0.85 | 1.09 | -0.21 | 0.03 | |
| Change in Other Net Operating Assets | -0.21 | -0.5 | 0.05 | 0.66 | 0.15 | |
| Operating Cash Flow | -18.47 | -18.87 | -18.87 | -14.69 | -12.37 | |
| Capital Expenditures | - | -0.02 | -0.02 | -0.12 | -0.09 | |
| Investment in Securities | - | 5 | 10.24 | -14.66 | - | |
| Investing Cash Flow | - | 4.98 | 10.22 | -14.77 | -0.09 | |
| Long-Term Debt Repaid | -0.1 | -0.09 | -0.09 | -0.08 | -0.02 | |
| Net Debt Issued (Repaid) | -0.1 | -0.09 | -0.09 | -0.08 | -0.02 | |
| Issuance of Common Stock | 28.94 | 13.38 | 12.73 | - | 42.64 | |
| Other Financing Activities | -0.4 | -0.28 | - | - | -0.85 | |
| Financing Cash Flow | 28.45 | 13.01 | 12.64 | -0.08 | 41.77 | |
| Foreign Exchange Rate Adjustments | 0.47 | -0.53 | 0.49 | -0.02 | 0.1 | |
| Net Cash Flow | 10.46 | -1.41 | 4.49 | -29.57 | 29.41 | |
| Free Cash Flow | -18.47 | -18.9 | -18.88 | -14.81 | -12.46 | |
| Free Cash Flow Margin | - | - | -34217.53% | -11166.38% | -9303.42% | |
| Free Cash Flow Per Share | -0.56 | -0.83 | -1.45 | -1.25 | -1.23 | |
| Cash Income Tax Paid | 0.05 | 0.09 | 0.13 | 0 | 0 | |
| Levered Free Cash Flow | -10.5 | -11.47 | -9.8 | -8.2 | -6.97 | |
| Unlevered Free Cash Flow | -10.5 | -11.47 | -9.8 | -8.2 | -6.97 | |
| Change in Working Capital | -1.01 | -1.08 | 0.44 | 1.51 | -0.33 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.